September 4, 2018 07:28 AM EDT
Pharma

Strug­gling MannKind sees shares rock­et up on $105M-plus al­liance with Unit­ed on in­haled tre­pros­tinil

John Carroll

Editor & Founder

The long suf­fer­ing MannKind Corp $MNKD is pock­et­ing $55 mil­lion as it launch­es a new col­lab­o­ra­tion with Unit­ed Ther­a­peu­tics to use its tech to de­vel­op …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

CDER Di­rec­tor Pa­trizia Cavaz­zoni to step down ahead of Trump pres­i­den­cy

In­tel­lia to cut work­force by 27%, plans com­mer­cial­iza­tion of first CRISPR ther­a­py in 2027

Ex­clu­sive: Mod­er­na's for­mer top sci­en­tist has a new start­up us­ing AI to im­prove mR­NA ther­a­pies

Lil­ly ven­tures in­to pul­monary fi­bro­sis with start­up Me­di­ar

John Maraganore turns to ex-Al­ny­lam col­league to lead his lat­est RNAi bet; Amy­lyx names com­mer­cial chief

Four biotechs emerge with $800M and in-li­censed as­sets on Fri­day

A service from the Financial Times